397 related articles for article (PubMed ID: 21825241)
1. The dynamics of cortical and hippocampal atrophy in Alzheimer disease.
Sabuncu MR; Desikan RS; Sepulcre J; Yeo BT; Liu H; Schmansky NJ; Reuter M; Weiner MW; Buckner RL; Sperling RA; Fischl B;
Arch Neurol; 2011 Aug; 68(8):1040-8. PubMed ID: 21825241
[TBL] [Abstract][Full Text] [Related]
2. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
[TBL] [Abstract][Full Text] [Related]
4. Topography of cortical thinning areas associated with hippocampal atrophy (HA) in patients with Alzheimer's disease (AD).
Kim GH; Jeon S; Seo SW; Kim MJ; Kim JH; Roh JH; Shin JS; Kim CH; Im K; Lee JM; Qiu A; Kim ST; Na DL
Arch Gerontol Geriatr; 2012; 54(2):e122-9. PubMed ID: 22088936
[TBL] [Abstract][Full Text] [Related]
5. Regional cortical thinning predicts worsening apathy and hallucinations across the Alzheimer disease spectrum.
Donovan NJ; Wadsworth LP; Lorius N; Locascio JJ; Rentz DM; Johnson KA; Sperling RA; Marshall GA;
Am J Geriatr Psychiatry; 2014 Nov; 22(11):1168-79. PubMed ID: 23890751
[TBL] [Abstract][Full Text] [Related]
6. Progressive cortical thinning and subcortical atrophy in dementia with Lewy bodies and Alzheimer's disease.
Mak E; Su L; Williams GB; Watson R; Firbank MJ; Blamire AM; O'Brien JT
Neurobiol Aging; 2015 Apr; 36(4):1743-1750. PubMed ID: 25649023
[TBL] [Abstract][Full Text] [Related]
7. The influence of hippocampal atrophy on the cognitive phenotype of dementia with Lewy bodies.
Elder GJ; Mactier K; Colloby SJ; Watson R; Blamire AM; O'Brien JT; Taylor JP
Int J Geriatr Psychiatry; 2017 Nov; 32(11):1182-1189. PubMed ID: 28425185
[TBL] [Abstract][Full Text] [Related]
8. Spatially distinct atrophy is linked to β-amyloid and tau in preclinical Alzheimer disease.
Wang L; Benzinger TL; Hassenstab J; Blazey T; Owen C; Liu J; Fagan AM; Morris JC; Ances BM
Neurology; 2015 Mar; 84(12):1254-60. PubMed ID: 25716355
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal change of biomarkers in cognitive decline.
Lo RY; Hubbard AE; Shaw LM; Trojanowski JQ; Petersen RC; Aisen PS; Weiner MW; Jagust WJ;
Arch Neurol; 2011 Oct; 68(10):1257-66. PubMed ID: 21670386
[TBL] [Abstract][Full Text] [Related]
10. The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease.
Hohman TJ; Bell SP; Jefferson AL;
JAMA Neurol; 2015 May; 72(5):520-9. PubMed ID: 25751166
[TBL] [Abstract][Full Text] [Related]
11. Relevance of magnetic resonance imaging for early detection and diagnosis of Alzheimer disease.
Teipel SJ; Grothe M; Lista S; Toschi N; Garaci FG; Hampel H
Med Clin North Am; 2013 May; 97(3):399-424. PubMed ID: 23642578
[TBL] [Abstract][Full Text] [Related]
12. The cortical signature of prodromal AD: regional thinning predicts mild AD dementia.
Bakkour A; Morris JC; Dickerson BC
Neurology; 2009 Mar; 72(12):1048-55. PubMed ID: 19109536
[TBL] [Abstract][Full Text] [Related]
13. Neuro-degeneration profile of Alzheimer's patients: A brain morphometry study.
Ramos Bernardes da Silva Filho S; Oliveira Barbosa JH; Rondinoni C; Dos Santos AC; Garrido Salmon CE; da Costa Lima NK; Ferriolli E; Moriguti JC
Neuroimage Clin; 2017; 15():15-24. PubMed ID: 28459000
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
[TBL] [Abstract][Full Text] [Related]
15. One-year Follow-up Study of Hippocampal Subfield Atrophy in Alzheimer's Disease and Normal Aging.
Madusanka N; Choi HK; So JH; Choi BK; Park HG
Curr Med Imaging Rev; 2019; 15(7):699-709. PubMed ID: 32008518
[TBL] [Abstract][Full Text] [Related]
16. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps.
Apostolova LG; Dutton RA; Dinov ID; Hayashi KM; Toga AW; Cummings JL; Thompson PM
Arch Neurol; 2006 May; 63(5):693-9. PubMed ID: 16682538
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein e4 affects topographical changes in hippocampal and cortical atrophy in Alzheimer's disease dementia: a five-year longitudinal study.
Kim YJ; Cho H; Kim YJ; Ki CS; Chung SJ; Ye BS; Kim HJ; Kim JH; Kim ST; Lee KH; Jeon S; Lee JM; Chin J; Kim JH; Na DL; Seong JK; Seo SW
J Alzheimers Dis; 2015; 44(4):1075-85. PubMed ID: 25391384
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of Regional Brain Atrophy Patterns Associated with Distinct Progression Rates in Alzheimer's Disease.
Byun MS; Kim SE; Park J; Yi D; Choe YM; Sohn BK; Choi HJ; Baek H; Han JY; Woo JI; Lee DY;
PLoS One; 2015; 10(11):e0142756. PubMed ID: 26618360
[TBL] [Abstract][Full Text] [Related]
19. Improved prediction of Alzheimer's disease with longitudinal white matter/gray matter contrast changes.
Grydeland H; Westlye LT; Walhovd KB; Fjell AM
Hum Brain Mapp; 2013 Nov; 34(11):2775-85. PubMed ID: 22674625
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer Disease.
Tarawneh R; Head D; Allison S; Buckles V; Fagan AM; Ladenson JH; Morris JC; Holtzman DM
JAMA Neurol; 2015 Jun; 72(6):656-65. PubMed ID: 25867677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
